Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chin B Eap

Showing results (131-140 of 179) with videos related to

Pageof 18
Sort By:
Mayo Clinic Proceedings|March 20, 2018
Associations of Urinary Caffeine and Caffeine Metabolites With Arterial Stiffness in a Large Population-Based StudyBelen Ponte, Menno Pruijm, Daniel Ackermann, et al.
BMC Medical Genomics|June 4, 2008
Association of ABCB1 genetic variants with renal function in Africans and in CaucasiansMurielle Bochud, Chin B Eap, Marc Maillard, et al.
Translational Psychiatry|November 15, 2024
Psychotropic-induced weight gain and telomere length: results from a one-year longitudinal study and a large population-based cohortMarianna Piras, Jue Lin, Marie Catherine Sadler, et al.
Clinical Pharmacokinetics|February 2, 2013
Population pharmacokinetic study of memantine: effects of clinical and genetic factorsMuriel Noetzli, Monia Guidi, Karsten Ebbing, et al.
Revue Medicale Suisse|May 7, 2016
[SSRI antidepressant use during pregnancy and the assessment of the risk-benefit ratio]Etienne Weisskopf, Céline J Fischer Fumeaux, Myriam Bickle Graz, et al.
The Journal of Clinical Psychiatry|April 3, 2020
Evaluation of Cardiometabolic Risk in a Large Psychiatric Cohort and Comparison With a Population-Based Sample in SwitzerlandCéline Dubath, Aurélie Delacrétaz, Anaïs Glatard, et al.
Pharmacogenetics and Genomics|February 25, 2009
In vivo analysis of efavirenz metabolism in individuals with impaired CYP2A6 functionJulia di Iulio, Aurélie Fayet, Mona Arab-Alameddine, et al.
Gene|July 12, 2017
Association of variants in SH2B1 and RABEP1 with worsening of low-density lipoprotein and glucose parameters in patients treated with psychotropic drugsAurélie Delacrétaz, Adna Zdralovic, Frederik Vandenberghe, et al.
Basic & Clinical Pharmacology & Toxicology|February 12, 2022
Olanzapine-associated dose-dependent alterations for weight and metabolic parameters in a prospective cohortGeorgios Schoretsanitis, Céline Dubath, Claire Grosu, et al.
Molecular Psychiatry|May 12, 2023
Identification of four novel loci associated with psychotropic drug-induced weight gain in a Swiss psychiatric longitudinal study: A GWAS analysisJennifer Sjaarda, Aurélie Delacrétaz, Céline Dubath, et al.
Pageof 18

Showing results (131-140 of 179) with videos related to

Sort By:
Pageof 18
Mayo Clinic Proceedings|March 20, 2018
Associations of Urinary Caffeine and Caffeine Metabolites With Arterial Stiffness in a Large Population-Based StudyBelen Ponte, Menno Pruijm, Daniel Ackermann, et al.
BMC Medical Genomics|June 4, 2008
Association of ABCB1 genetic variants with renal function in Africans and in CaucasiansMurielle Bochud, Chin B Eap, Marc Maillard, et al.
Translational Psychiatry|November 15, 2024
Psychotropic-induced weight gain and telomere length: results from a one-year longitudinal study and a large population-based cohortMarianna Piras, Jue Lin, Marie Catherine Sadler, et al.
Clinical Pharmacokinetics|February 2, 2013
Population pharmacokinetic study of memantine: effects of clinical and genetic factorsMuriel Noetzli, Monia Guidi, Karsten Ebbing, et al.
Revue Medicale Suisse|May 7, 2016
[SSRI antidepressant use during pregnancy and the assessment of the risk-benefit ratio]Etienne Weisskopf, Céline J Fischer Fumeaux, Myriam Bickle Graz, et al.
The Journal of Clinical Psychiatry|April 3, 2020
Evaluation of Cardiometabolic Risk in a Large Psychiatric Cohort and Comparison With a Population-Based Sample in SwitzerlandCéline Dubath, Aurélie Delacrétaz, Anaïs Glatard, et al.
Pharmacogenetics and Genomics|February 25, 2009
In vivo analysis of efavirenz metabolism in individuals with impaired CYP2A6 functionJulia di Iulio, Aurélie Fayet, Mona Arab-Alameddine, et al.
Gene|July 12, 2017
Association of variants in SH2B1 and RABEP1 with worsening of low-density lipoprotein and glucose parameters in patients treated with psychotropic drugsAurélie Delacrétaz, Adna Zdralovic, Frederik Vandenberghe, et al.
Basic & Clinical Pharmacology & Toxicology|February 12, 2022
Olanzapine-associated dose-dependent alterations for weight and metabolic parameters in a prospective cohortGeorgios Schoretsanitis, Céline Dubath, Claire Grosu, et al.
Molecular Psychiatry|May 12, 2023
Identification of four novel loci associated with psychotropic drug-induced weight gain in a Swiss psychiatric longitudinal study: A GWAS analysisJennifer Sjaarda, Aurélie Delacrétaz, Céline Dubath, et al.
Pageof 18